Prevention and treatment of atherosclerosis

Springer Nature

2022

x, 538 p.

Handbook of experimental pharmacology ; vol. 270

9783030860783

Diet, Life Style, Smoking.- Blood Pressure Lowering.- Glycemic Control in Diabetes.- LDL-Cholesterol Lowering.- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation).- Triglyceride Rich Lipoproteins.- HDL.- Lipoprotein(a).- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome.- Nutraceuticals / Functional Food.- Adipose Tissue (WAT, BAT).- Microbiota and Cardiometabolic Disease.- SMCs, Matrix.- Immune Modulation.- NETs and Neutrophils.- Genomic Strategies Towards Identification of Novel Therapeutic Targets.- Non Coding RNAs.- Metabolomics, Lipidomics.- Epigenomics

This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets.

Английский